Literature DB >> 18819072

Enhanced B-cell activation mediated by TLR4 and BCR crosstalk.

Susana Minguet1, Elaine P Dopfer, Careen Pollmer, Marina A Freudenberg, Chris Galanos, Michael Reth, Michael Huber, Wolfgang W Schamel.   

Abstract

Despite the important role of B lymphocytes as a bridge between the innate and the adaptive immune system, little is known regarding lipopolysaccharide (LPS) recognition, activation of signalling networks or conceivable cooperation between LPS and the B-cell antigen receptor (BCR). Here, we show that primary B cells can efficiently discriminate between different LPS chemotypes, responding with at least 100-fold higher sensitivity to rough-form LPS compared with smooth-form LPS. Using genetically modified mice, we demonstrate that B lymphocytes recognize all LPS chemotypes via Toll-like receptor 4 (TLR4). In addition, we dissect the signalling pathways that lead to CD69 upregulation upon TLR4 and BCR activation in primary B cells. Our data suggest that TLR4 and BCR induce CD69 transcription via two distinct sets of signalling molecules, exerting quantitative and qualitative differences in B-cell activation. Finally, we show that simultaneous stimulation of TLR4 and BCR additively elevates B-cell activation. In contrast, co-engagement of TLR4 and BCR by antigen-coupled LPS synergistically enhances activation of B cells, pointing out attractive targets for signalling crosstalk in B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18819072     DOI: 10.1002/eji.200738094

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  34 in total

1.  Molecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virus.

Authors:  Yuan Fang; Thomas Rowe; Alberto J Leon; David Banner; Ali Danesh; Luoling Xu; Longsi Ran; Steven E Bosinger; Yi Guan; Honglin Chen; Cheryl C Cameron; Mark J Cameron; David J Kelvin
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

Review 2.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

3.  LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14.

Authors:  Leonid Tarassishin; Hyeon-Sook Suh; Sunhee C Lee
Journal:  Glia       Date:  2014-03-21       Impact factor: 7.452

4.  Nontransformed, GM-CSF-dependent macrophage lines are a unique model to study tissue macrophage functions.

Authors:  György Fejer; Mareike Dorothee Wegner; Ildiko Györy; Idan Cohen; Peggy Engelhard; Elena Voronov; Thomas Manke; Zsolt Ruzsics; Lars Dölken; Olivia Prazeres da Costa; Nora Branzk; Michael Huber; Antje Prasse; Robert Schneider; Ron N Apte; Chris Galanos; Marina A Freudenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-24       Impact factor: 11.205

Review 5.  Toll-like receptors--sentries in the B-cell response.

Authors:  Isabelle Bekeredjian-Ding; Gaetan Jego
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

Review 6.  Innate B cell helpers reveal novel types of antibody responses.

Authors:  Carola G Vinuesa; Pheh-Ping Chang
Journal:  Nat Immunol       Date:  2013-01-18       Impact factor: 25.606

7.  A structurally distinct human mycoplasma protein that generically blocks antigen-antibody union.

Authors:  Rajesh K Grover; Xueyong Zhu; Travis Nieusma; Teresa Jones; Isabel Boreo; Amanda S MacLeod; Adam Mark; Sherry Niessen; Helen J Kim; Leopold Kong; Nacyra Assad-Garcia; Keehwan Kwon; Marta Chesi; Vaughn V Smider; Daniel R Salomon; Diane F Jelinek; Robert A Kyle; Richard B Pyles; John I Glass; Andrew B Ward; Ian A Wilson; Richard A Lerner
Journal:  Science       Date:  2014-02-07       Impact factor: 47.728

Review 8.  Toll-like receptors and B cells: functions and mechanisms.

Authors:  Claire M Buchta; Gail A Bishop
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

Review 9.  Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment.

Authors:  Samaresh Sau; Hashem O Alsaab; Ketki Bhise; Rami Alzhrani; Ghazal Nabil; Arun K Iyer
Journal:  J Control Release       Date:  2018-01-31       Impact factor: 9.776

10.  S-glutathionylation activates STIM1 and alters mitochondrial homeostasis.

Authors:  Brian J Hawkins; Krishna M Irrinki; Karthik Mallilankaraman; Yu-Chin Lien; Youjun Wang; Cunnigaiper D Bhanumathy; Ramasamy Subbiah; Michael F Ritchie; Jonathan Soboloff; Yoshihiro Baba; Tomohiro Kurosaki; Suresh K Joseph; Donald L Gill; Muniswamy Madesh
Journal:  J Cell Biol       Date:  2010-08-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.